CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 2,145 shares (grant or award)
- 4 Grant or award Director acquired 2,145 shares (grant or award)
- 4 Grant or award Director acquired 2,145 shares (grant or award)
- 4 Grant or award Director acquired 2,145 shares (grant or award)
- 4 Grant or award Director acquired 2,145 shares (grant or award)
- 4 Grant or award Director acquired 2,145 shares (grant or award)
- 4 Grant or award Director acquired 2,145 shares (grant or award)
- 4 Open-market sale EVP & Chief Commercial Officer sold 1,009 shares at an average $94.82 ($95,670)
- 4 Open-market sale EVP and General Counsel sold 1,329 shares at $100.00 ($132,900)
- 4 Open-market sale EVP & Chief Tech Ops Officer sold 363 shares at $113.68 ($41,266)
- 4 Open-market sale EVP and General Counsel sold 313 shares at $113.67 ($35,579)
- 4 Open-market sale Pinion John Richard sold 363 shares at $113.69 ($41,269)
- 4 Open-market sale SVP, Chief Accounting Officer sold 142 shares at $113.67 ($16,141)
- 4 Open-market sale CBO & EVP sold 363 shares at $113.69 ($41,269)
- 4 Shares withheld for taxes President & CEO gave up 852 shares (to pay taxes)
- 4 Open-market sale EVP & Chief Commercial Officer sold 700 shares at an average $113.67 ($79,572)
- 4 Open-market sale EVP and Chief Medical Officer sold 364 shares at $113.67 ($41,376)
- 4 Open-market sale President & CEO sold 30,000 shares at $107.80 ($3,234,000)
- 4 Open-market sale EVP & Chief Commercial Officer sold 396 shares at $104.28 ($41,295)
Page 10 of 32 · 627 filings